phase ii study of petosemtamab and pembrolizumab for recurrent/metastatic hnscc
Published 3 weeks ago • 42 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
3:26
phase ii trial of pembro & epacadostat in patients with recurrent clear cell carcinoma of the ovary
-
8:23
results from a phase i study of amg 160
-
0:56
belief: phase 2 trial of erlotinib plus bevacizumab for non-small cell lung cancer
-
4:54
background of the keynote-158 trial for pembrolizumab in advanced mesothelioma
-
2:15
phase 2 trial of chemotherapy plus gefitinib as first-line treatment for lung adenocarcinoma
-
1:20
ctcs, emt & immunosuppresive cells in metastatic breast cancer
-
6:45
integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma
-
4:49
botensilimab plus balstilimab for metastatic heavily pretreated mss colorectal cancer
-
2:21
phase i study of ipatasertib with chemotherapy and atezolizumab
-
1:41
stride: phase 2 study of sipuleucel-t in metastatic castration-resistant prostate cancer
-
3:54
papmet2: cabozantinib with or without atezolizumab in prcc
-
9:27
phase 2 results - metastatic cutaneous squamous cell carcinoma (mcscc)
-
14:00
a step-by-step approach to managing mesothelioma
-
5:29
combination of camonsertib plus parpi shows clinical activity in ddr-aberrant tumours
-
7:46
results from the phase 2 fast study of astellas’ investigational zolbetuximab
-
2:15
a phase i study investigating ruxolitinib and abemaciclib for primary or secondary myelofibrosis
-
1:37
results of phase i study reach primary end point for mcrpc
-
0:53
belief: phase 2 trial of erlotinib and bevacizumab in non-small cell lung cancer